262 related articles for article (PubMed ID: 30486276)
61. Erianin-Loaded Photo-Responsive Dendrimer Mesoporous Silica Nanoparticles: Exploration of a Psoriasis Treatment Method.
Yu H; Liu Y; Zheng F; Chen W; Wei K
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234865
[TBL] [Abstract][Full Text] [Related]
62. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
63. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
Prabha G; Raj V
Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054
[TBL] [Abstract][Full Text] [Related]
64. Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells.
Salve R; Kumar P; Chaudhari BP; Gajbhiye V
J Pharm Sci; 2023 May; 112(5):1450-1459. PubMed ID: 36669561
[TBL] [Abstract][Full Text] [Related]
65. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
Wu L; Wu M; Zeng Y; Zhang D; Zheng A; Liu X; Liu J
Nanotechnology; 2015 Jan; 26(2):025102. PubMed ID: 25517859
[TBL] [Abstract][Full Text] [Related]
66. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
[TBL] [Abstract][Full Text] [Related]
67. Core-Shell Imidazoline-Functionalized Mesoporous Silica Superparamagnetic Hybrid Nanoparticles as a Potential Theranostic Agent for Controlled Delivery of Platinum(II) Compound.
Abedi M; Abolmaali SS; Abedanzadeh M; Farjadian F; Mohammadi Samani S; Tamaddon AM
Int J Nanomedicine; 2020; 15():2617-2631. PubMed ID: 32368044
[TBL] [Abstract][Full Text] [Related]
68. Biofilm-encapsulated nano drug delivery system for the treatment of colon cancer.
Shi J; Ma Z; Pan H; Liu Y; Chu Y; Wang J; Chen L
J Microencapsul; 2020 Nov; 37(7):481-491. PubMed ID: 32700606
[TBL] [Abstract][Full Text] [Related]
69. Mesoporous silica@chitosan@gold nanoparticles as "on/off" optical biosensor and pH-sensitive theranostic platform against cancer.
Esmaeili Y; Khavani M; Bigham A; Sanati A; Bidram E; Shariati L; Zarrabi A; Jolfaie NA; Rafienia M
Int J Biol Macromol; 2022 Mar; 202():241-255. PubMed ID: 35041881
[TBL] [Abstract][Full Text] [Related]
70. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
71. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
[TBL] [Abstract][Full Text] [Related]
72. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
[TBL] [Abstract][Full Text] [Related]
73. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
[TBL] [Abstract][Full Text] [Related]
74. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging.
Xie M; Shi H; Li Z; Shen H; Ma K; Li B; Shen S; Jin Y
Colloids Surf B Biointerfaces; 2013 Oct; 110():138-47. PubMed ID: 23711784
[TBL] [Abstract][Full Text] [Related]
75. Formation of enzymatic/redox-switching nanogates on mesoporous silica nanoparticles for anticancer drug delivery.
Luo W; Xu X; Zhou B; He P; Li Y; Liu C
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():855-861. PubMed ID: 30948123
[TBL] [Abstract][Full Text] [Related]
76. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
77. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.
Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM
Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655
[TBL] [Abstract][Full Text] [Related]
78. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis.
Elbaz NM; Khalil IA; Abd-Rabou AA; El-Sherbiny IM
Int J Biol Macromol; 2016 Nov; 92():254-269. PubMed ID: 27397719
[TBL] [Abstract][Full Text] [Related]
79. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
[TBL] [Abstract][Full Text] [Related]
80. Capecitabine loaded potato starch-chitosan nanoparticles: A novel approach for targeted therapy and improved outcomes in aggressive colon cancer.
Bhattacharya S; Page A; Shinde P
Eur J Pharm Biopharm; 2024 Jul; 200():114328. PubMed ID: 38763329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]